Discover

APGE
Apogee Therapeutics, Inc.
132.77
2 x 95.56
4 x 133.00
bid
ask
+
0.04
0.03%
3 @ 04:00 PM
132.65 -0.13 (0.09%)
Ytd75.90%
1y199.98%
132.69
day range
132.85
34.34
52 week range
133.16
Open132.75Prev Close132.73Low132.69High132.85Mkt Cap9.98B
Vol3.48MAvg Vol2.40MEPS-4.33P/EN/AForward P/E-25.59
Beta0.62Short Ratio9.81Inst. Own131.59%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1050-d Avg91.77200-d Avg73.181yr Est130.53

APGE News

Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders
globenewswire.com
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Apogee (NASDAQ: APGE) for po

This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
fool.com
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?

AbbVie knows how to plan ahead.

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
zacks.com
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, ap

Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy
benzinga.com
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9

Major M&A deals this week include: Adobe buys Topaz Labs, Rise Baking Company purchases Jimmy&#3

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?
gurufocus.com
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 2

Biotech ETF Index Surges 10% After Rebalance
etftrends.com
Biotech ETF Index Surges 10% After Rebalance

After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs

Is AbbVie a Buy After Its Purchase of Apogee?
fool.com
Is AbbVie a Buy After Its Purchase of Apogee?

The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 bill

benzinga.com
Stifel Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135

Stifel analyst Akash Tewari downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Hold and rai

Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi

This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
benzinga.com
This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See

benzinga.com
Mizuho Downgrades Apogee Therapeutics to Neutral, Raises Price Target to $135

Mizuho analyst Joseph Catanzaro downgrades Apogee Therapeutics (NASDAQ:APGE) from Outperform to N

benzinga.com
Deutsche Bank Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135

Deutsche Bank analyst David Hoang downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Hold a

AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst
benzinga.com
AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst

AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology

This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
benzinga.com
This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Piper Sandler upgraded SNPS, JP Morgan upgrad

benzinga.com
Citigroup Downgrades Apogee Therapeutics to Neutral, Raises Price Target to $135

Citigroup analyst Geoff Meacham downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Neutral

benzinga.com
RBC Capital Maintains Sector Perform on Apogee Therapeutics, Raises Price Target to $135

RBC Capital analyst Brian Abrahams maintains Apogee Therapeutics (NASDAQ:APGE) with a Sector Perf

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo

benzinga.com
UBS Downgrades Apogee Therapeutics to Neutral, Raises Price Target to $135.11

UBS analyst Michael Yee downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Neutral and rais

This Zions Bancorp Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
benzinga.com
This Zions Bancorp Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Wall Street analysts changed ratings for PRIM, ZION, and APGE. Check out analysts' views on thes

benzinga.com
Wedbush Downgrades Apogee Therapeutics to Neutral, Maintains Price Target to $135

Wedbush analyst David Nierengarten downgrades Apogee Therapeutics (NASDAQ:APGE) from Outperform t

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monday
benzinga.com
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On

U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Thera

Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
benzinga.com
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 poi

AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
benzinga.com
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition

AbbVie will acquire Apogee for $10.9 billion, adding late-stage immunology and asthma assets to its

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar

benzinga.com
AbbVie To Acquire Apogee And Its Diverse Pipeline Of Multiple Clinical-Stage Candidates In Developme

Proposed acquisition adds a diverse pipeline of assets focused on elevating the standard of care for

Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket

SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth

benzinga.com
Reported Friday, 'AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics' - FT

https://www.ft.com/content/cb5e94aa-1687-47fe-b55a-82e273e8b1bd?syn-25a6b1a6=1 

benzinga.com
RBC Capital Maintains Sector Perform on Apogee Therapeutics, Raises Price Target to $97

RBC Capital analyst Brian Abrahams maintains Apogee Therapeutics (NASDAQ:APGE) with a Sector Perf